US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says
(Reuters) -The impact of U.S. President Donald Trump's plan to levy import duties on pharmaceutical...
10th September, 2025
(Reuters) -The impact of U.S. President Donald Trump's plan to levy import duties on pharmaceutical...
10th September, 2025
LONDON (Reuters) -Teton.ai, a company that uses proprietary AI and computer vision technology to pro...
9th September, 2025
By Gianluca Lo Nostro (Reuters) - Paris prosecutors opened a criminal probe into Philips in June ove...
8th September, 2025
By Charlotte Greenfield ISLAMABAD (Reuters) -The World Health Organization has asked Taliban authori...
8th September, 2025
BELGRADE (Reuters) -Greece and OpenAI signed a memorandum of understanding on Friday to broaden acce...
6th September, 2025
By Charlotte Van Campenhout and Ammu Kannampilly BRUSSELS (Reuters) -U.S.-funded contraceptives and...
5th September, 2025
GENEVA (Reuters) -Mpox no longer represents a international health emergency, the World Health Organ...
5th September, 2025
WASHINGTON (Reuters) -Former U.S. President Joe Biden recently underwent surgery to remove cancerous...
4th September, 2025
LONDON (Reuters) -Shares in French drugmaker Sanofi fell more than 9% on Thursday after late-stage t...
4th September, 2025
BEIJING (Reuters) -When Russian President Vladimir Putin walked shoulder to shoulder with China's Pr...
3rd September, 2025
(Reuters) -Swiss drugmaker Novartis has signed a licensing and options deal with Argo Biopharmaceuti...
3rd September, 2025
(Reuters) -UK shares rebounded on Wednesday, led by gains in healthcare and mining stocks, after suf...
3rd September, 2025